SCHEMBL4476443

SCHEMBL4476443

Cc1cc(Nc2ncnc3ccc(N4CCOCC4)cc23)ccc1Oc1ccccc1OC1CCN(C(=O)O)CC1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 19/20 0.60
EGFR P00533 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4464044 0.93 ERBB2 (0.68) ERBB2EGFR
SCHEMBL4464003 0.86 ERBB2 (0.55) ERBB2EGFR
SCHEMBL4468667 0.85 ERBB2 (0.80) ERBB2EGFR
SCHEMBL4467738 0.83 ERBB2 (0.84) ERBB2
SCHEMBL4476374 0.79 ERBB2 (0.79) ERBB2EGFR
SCHEMBL4466005 0.78 ERBB2 (0.63) ERBB2EGFR
SCHEMBL4455092 0.78 ERBB2 (0.52) ERBB2EGFR
SCHEMBL4465878 0.78 ERBB2 (0.71) ERBB2EGFR
SCHEMBL4471215 0.77 ERBB2 (0.84) ERBB2
SCHEMBL4466009 0.77 ERBB2 (0.79) ERBB2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585869-B2 Substituted heterocylces for the treatment of abnormal cell growth PFIZER, INC. (US) 2009-09-08 US claimed